.png){kind=icon}
-
Commercialization
市场访问和第IV阶段解决方案
-
Data & Technology Solutions
Data Capabilities Design Better Studies Improve Study Recruitment Reduce Study Risk Gain Operational Insights Ensure Data Quality Access Central Laboratory Information Empower Your Data Maximize Product Access Transform Patient SafetyClinical Development
Clinical Pharmacology 早期临床/阶段IIA Phase IIb / III Services Clinical Data Management Analysis and Reporting Regulatory Services 第四阶段 Clinical Research Unit Virtual Tours Clinical-Biotech Decentralized Clinical Trials
-
Call Us
The Americas
+ 1.888.COVANCE（+1.888.268.2623） 1.609.452.4440Europe/Africa
+00.800.2682.2682 +44.1423.500888Asia/Pacific
+800.6568.3000 +65.6.5686588Global Office Locations
-
Media Relations
Request an Interview Request a Speaker亚博全站官网
设备订购投资者
Investor RelationsJob Seekers
Covance Careers
yaboapp体育官网
CAKI-1
| Parameter | 信息 |
|---|---|
| Implant Type | Cells |
(The above parameters are from one study. For further information on this cell line and other parameters, including different strains, vendors, implant type and location and/or standards of care, please contact Covance.)
组型：Renal
肿瘤线：Human
Copyright © 2020 Covance Inc. All rights reserved.
Covance is a business segment of LabCorp, a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. COVANCE is a registered trademark and the marketing name for Covance Inc. and its subsidiaries around the world.
Covance is a business segment of LabCorp, a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. COVANCE is a registered trademark and the marketing name for Covance Inc. and its subsidiaries around the world.